about
Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brainOn the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosisThe role of the Epstein-Barr virus in the pathogenesis of some autoimmune disorders - Similarities and differencesLupus and Epstein-BarrIs Systemic Lupus Erythematosus Associated With a Declined Immunogenicity and Poor Safety of Influenza Vaccination?: A Systematic Review and Meta-Analysis.Diet, microbiota and autoimmune diseases.Infection in systemic lupus erythematosus: friend or foe?What causes alopecia areata?A Review of Autoimmune Disease Hypotheses with Introduction of the "Nucleolus" Hypothesis.Treatment with a toll-like receptor inhibitory GpG oligonucleotide delays and attenuates lupus nephritis in NZB/W mice.A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).Latent membrane protein 1, the EBV-encoded oncogenic mimic of CD40, accelerates autoimmunity in B6.Sle1 micePathogenesis and potential therapeutic targets in systemic lupus erythematosus: from bench to bedsideImplications of the parent-into-F1 model for human lupus pathogenesis: roles for cytotoxic T lymphocytes and viral pathogens.Measurement of CD8+ and CD4+ T Cell Frequencies Specific for EBV LMP1 and LMP2a Using mRNA-Transfected DCsInfluenza vaccination can induce new-onset anticardiolipins but not β2-glycoprotein-I antibodies among patients with systemic lupus erythematosus.Effects of IRF5 lupus risk haplotype on pathways predicted to influence B cell functionsMurine gammaherpesvirus 68 infection protects lupus-prone mice from the development of autoimmunity.The Lived Experience of Lupus Flares: Features, Triggers, and Management in an Australian Female Cohort.Current status of lupus geneticsThe curiously suspicious: a role for Epstein-Barr virus in lupus.Recent advances and opportunities in research on lupus: environmental influences and mechanisms of disease.Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.Sex-specific environmental influences on the development of autoimmune diseasesPredictors of autoimmune disease: autoantibodies and beyond.Infection--genetics relationship in systemic lupus erythematosus.Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4+ T Cells.Environmental exposures, epigenetic changes and the risk of lupus.Role of CD4+ cytotoxic T lymphocytes in the control of viral diseases and cancer.The genomics of autoimmune disease in the era of genome-wide association studies and beyondInterferon regulatory factor 5 and autoimmune lupus.Effect of high dose vitamin C on Epstein-Barr viral infection.Multiple granulomatous lung lesions in a patient with Epstein-Barr-virus-induced mononucleosis and new-onset systemic lupus erythematosus: a case report.HPV and systemic lupus erythematosus: a mosaic of potential crossreactions.Epstein-Barr virus antibodies mark systemic lupus erythematosus and scleroderma patients negative for anti-DNA.Long-term carriers generate Epstein-Barr virus (EBV)-specific CD4(+) and CD8(+) polyfunctional T-cell responses which show immunodominance hierarchies of EBV proteins.Viral Impact in Autoimmune Diseases: Expanding the "X Chromosome-Nucleolus Nexus" Hypothesis.
P2860
Q24642187-7B9CCCC6-84A0-4127-8E2E-485A7CE73E84Q24645207-98CCDD14-492D-41AD-A0F6-1EBB8D940E91Q26866256-AB112659-B595-43EC-BD17-2A16A9685E5FQ26996511-77007DDD-D770-4215-9A7F-C62035BC93B8Q30388063-883E059F-C9F6-4568-8F90-84249D946023Q33564593-1C959DF3-AC81-40D2-87D7-8F479FE50A6BQ33696879-59C3D694-3904-4F80-957D-1C5DE7A7F678Q33889367-DB4B4D6E-5C27-4835-952A-482730CD235BQ34047060-404BA331-B326-4411-A338-FF71C2EC7227Q34114826-17634828-B715-46F7-A4E1-99F95D84C727Q34550781-5BE2821B-B002-429F-9FC1-6EAE84EAEEFDQ34622693-59C3A0B3-AA53-4DA1-BC8D-29ACF22B923FQ35309470-0AD13D32-6A7E-489A-909F-48F45DC995D3Q35479272-EF6CE98E-87AE-457B-A69A-28C5EA65141CQ35645903-34721354-E027-438A-AC60-4DC115668274Q35711767-97A7F426-A70C-4C03-B46B-D3111D1C4AD7Q35833264-AFCD6910-FCDE-40C4-90AF-90612313D8C6Q35935783-01B33826-2314-4147-9D05-B8978B1FC92BQ36112610-E567416A-6F74-4BEE-A5AF-F0602D9390C3Q36392330-9EDBA3D1-96FA-4EB5-B494-C68CABB47AFFQ36677016-9D91AFFA-A9FF-4229-B843-748970E5E761Q36725352-4A0B2BDF-FEF8-4761-8761-4C64F8A4B0AAQ37146126-A7F80DC9-5768-4245-B286-340112AF84DEQ37248651-F63AC98A-AFA2-4212-9AD1-AA693B72062BQ37264360-AE4C1052-F5DB-44BF-8DB4-134C0BEC12E3Q37625577-C0617A28-7C10-4FC4-A20C-A695A4358466Q37667998-9E5C545C-7B25-4640-9E59-301B308F7190Q37724776-78D2BD10-E112-4E9A-84A7-C34BD23346F5Q37773234-7A2B0B0C-CF47-4705-98B9-660374754143Q37946084-130548C5-AD0B-431B-B41C-EA58E6286F71Q38123907-3B2C72E4-8A6C-414A-AB4A-489926913439Q39427990-5CDBF577-395F-436B-B333-86E2F499906AQ40281142-2A480114-268A-4DF4-939E-85BB59B99F03Q40362384-DAEC455F-A69E-42E0-B454-E689C481DC47Q42259429-C7053838-430F-4A16-9A03-6E887D1A03FDQ45363582-73BA37CC-EABE-40B6-B22C-FB2BA7C49A69Q47151158-C427040D-8393-45ED-BDC3-3209FF3DA24E
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Epstein-Barr virus and systemic lupus erythematosus.
@ast
Epstein-Barr virus and systemic lupus erythematosus.
@en
Epstein-Barr virus and systemic lupus erythematosus.
@nl
type
label
Epstein-Barr virus and systemic lupus erythematosus.
@ast
Epstein-Barr virus and systemic lupus erythematosus.
@en
Epstein-Barr virus and systemic lupus erythematosus.
@nl
prefLabel
Epstein-Barr virus and systemic lupus erythematosus.
@ast
Epstein-Barr virus and systemic lupus erythematosus.
@en
Epstein-Barr virus and systemic lupus erythematosus.
@nl
P1476
Epstein-Barr virus and systemic lupus erythematosus.
@en
P2093
R Hal Scofield
P304
P356
10.1097/01.BOR.0000240355.37927.94
P577
2006-09-01T00:00:00Z